Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary.

MLA

Cluck, David B., et al. “Consensus Recommendations for the Use of Novel Antiretrovirals in Persons with HIV Who Are Heavily Treatment-Experienced and/or Have Multidrug-Resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An Executive Summary.” Pharmacotherapy, vol. 44, no. 5, May 2024, pp. 354–59. EBSCOhost, https://doi.org/10.1002/phar.2913.

APA

Cluck, D. B., Chastain, D. B., Murray, M., Durham, S. H., Chahine, E. B., Derrick, C., Dumond, J. B., Hester, E. K., Jeter, S. B., Johnson, M. D., Kilcrease, C., Kufel, W. D., Kwong, J., Ladak, A. F., Patel, N., Pérez, S. E., Poe, J. B., Bolch, C., Thomas, I., … Short, W. R. (2024). Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary. Pharmacotherapy, 44(5), 354–359. https://doi.org/10.1002/phar.2913

Chicago

Cluck, David B, Daniel B Chastain, Milena Murray, Spencer H Durham, Elias B Chahine, Caroline Derrick, Julie B Dumond, et al. 2024. “Consensus Recommendations for the Use of Novel Antiretrovirals in Persons with HIV Who Are Heavily Treatment-Experienced and/or Have Multidrug-Resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An Executive Summary.” Pharmacotherapy 44 (5): 354–59. doi:10.1002/phar.2913.